Phimosis: A rare complication of immunotherapy with durvalumab

Breakdown of phimosis referrals

Jorge Arturo Alatorre Alexander - INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS

Jorge ALATORRE ALEXANDER, Instituto Nacional de Enfermedades Respiratorias, Mexico City, INER, Lung Cáncer Clinic

PDF) Phimosis: A rare complication of immunotherapy with durvalumab

50631 PDFs Review articles in VITILIGO

Frequency of the different grades of phimosis according to age group

Luis VÁZQUEZ-LAVISTA, Medical Doctor, Médica Sur Clinic Foundation, Mexico City, Urology / kidney transplant

Adjuvant nivolumab is the first immunotherapy to demonstrate a benefit in the treatment of high-risk muscle-invasive urothelial carcinoma - Onco Americas

Luis G. Vázquez-Lavista MD - México, Perfil profesional

673662 PDFs Review articles in DOSING

Ipilimumab (Yervoy) Drug Information

Luis G. Vázquez-Lavista MD - México, Perfil profesional

Frequency of the different grades of phimosis according to age group

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations, Journal for ImmunoTherapy of Cancer